Oral clonidine reduces the requirement of prostaglandin E1 for induced hypotension. 1999

K Murakami, and T Mammoto, and T Kita, and Y Imai, and T Mashimo, and T Kirita, and M Sugimura, and Y Kishi
Department of Anesthesiology, Osaka Medical Center for Cancer and Cardiovascular Diseases, Japan.

OBJECTIVE To determine the effects of preanesthetic oral clonidine on the dose of prostaglandin EI (PGEI) required to produce hypotension during anesthesia. METHODS Oral placebo, 75 microg or 150 microg clonidine were administered 60 min prior to induction of anesthesia. Anesthesia was maintained with O2:N2O (30:70) and isoflurane 1.0%. After hemodynamic stabilization, an infusion of prostaglandin EI was started (0.05 microg x kg(-1) x min(-1)) and the rate of infusion was adjusted to maintain mean arterial pressure (MAP) between 60-70 mm Hg during operation. RESULTS Duration of hypotension in placebo, 75 microg and 150 microg preanesthetic oral clonidine treated groups were 132+/-46, 117+/-37 and 129+/-56 min, respectively. The PGEI requirement in each group were 1563+/-180 (28.6+/-3.2), 594+/-197 (10.8+/-3.6) and 283+/-30 (5.5+/-3.6) microg (microg x kg(-1)), respectively. In addition, blood loss in each group were 1461+/-389, 805+/-240 and 931+/-40 ml, respectively. CONCLUSIONS Preanesthetic oral clonidine decreased the dose of PGEI required to produce hypotension, and decreased the blood loss during operation.

UI MeSH Term Description Entries
D007023 Hypotension, Controlled Procedure in which arterial blood pressure is intentionally reduced in order to control blood loss during surgery. This procedure is performed either pharmacologically or by pre-surgical removal of blood. Controlled Hypotension,Hypotension, Induced,Induced Hypotension
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D003000 Clonidine An imidazoline sympatholytic agent that stimulates ALPHA-2 ADRENERGIC RECEPTORS and central IMIDAZOLINE RECEPTORS. It is commonly used in the management of HYPERTENSION. Catapres,Catapresan,Catapressan,Chlophazolin,Clofelin,Clofenil,Clonidine Dihydrochloride,Clonidine Hydrochloride,Clonidine Monohydrobromide,Clonidine Monohydrochloride,Clopheline,Dixarit,Gemiton,Hemiton,Isoglaucon,Klofelin,Klofenil,M-5041T,ST-155,Dihydrochloride, Clonidine,Hydrochloride, Clonidine,M 5041T,M5041T,Monohydrobromide, Clonidine,Monohydrochloride, Clonidine,ST 155,ST155
D005260 Female Females
D006339 Heart Rate The number of times the HEART VENTRICLES contract per unit of time, usually per minute. Cardiac Rate,Chronotropism, Cardiac,Heart Rate Control,Heartbeat,Pulse Rate,Cardiac Chronotropy,Cardiac Chronotropism,Cardiac Rates,Chronotropy, Cardiac,Control, Heart Rate,Heart Rates,Heartbeats,Pulse Rates,Rate Control, Heart,Rate, Cardiac,Rate, Heart,Rate, Pulse
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000316 Adrenergic alpha-Agonists Drugs that selectively bind to and activate alpha adrenergic receptors. Adrenergic alpha-Receptor Agonists,alpha-Adrenergic Receptor Agonists,Adrenergic alpha-Agonist,Adrenergic alpha-Receptor Agonist,Receptor Agonists, Adrenergic alpha,Receptor Agonists, alpha-Adrenergic,alpha-Adrenergic Agonist,alpha-Adrenergic Agonists,alpha-Adrenergic Receptor Agonist,Adrenergic alpha Agonist,Adrenergic alpha Agonists,Adrenergic alpha Receptor Agonist,Adrenergic alpha Receptor Agonists,Agonist, Adrenergic alpha-Receptor,Agonist, alpha-Adrenergic,Agonist, alpha-Adrenergic Receptor,Agonists, Adrenergic alpha-Receptor,Agonists, alpha-Adrenergic,Agonists, alpha-Adrenergic Receptor,Receptor Agonist, alpha-Adrenergic,Receptor Agonists, alpha Adrenergic,alpha Adrenergic Agonist,alpha Adrenergic Agonists,alpha Adrenergic Receptor Agonist,alpha Adrenergic Receptor Agonists,alpha-Agonist, Adrenergic,alpha-Agonists, Adrenergic,alpha-Receptor Agonist, Adrenergic,alpha-Receptor Agonists, Adrenergic
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

K Murakami, and T Mammoto, and T Kita, and Y Imai, and T Mashimo, and T Kirita, and M Sugimura, and Y Kishi
September 1998, Canadian journal of anaesthesia = Journal canadien d'anesthesie,
K Murakami, and T Mammoto, and T Kita, and Y Imai, and T Mashimo, and T Kirita, and M Sugimura, and Y Kishi
August 1993, Anesthesia and analgesia,
K Murakami, and T Mammoto, and T Kita, and Y Imai, and T Mashimo, and T Kirita, and M Sugimura, and Y Kishi
May 1984, Anesthesiology,
K Murakami, and T Mammoto, and T Kita, and Y Imai, and T Mashimo, and T Kirita, and M Sugimura, and Y Kishi
July 2000, Canadian journal of anaesthesia = Journal canadien d'anesthesie,
K Murakami, and T Mammoto, and T Kita, and Y Imai, and T Mashimo, and T Kirita, and M Sugimura, and Y Kishi
March 1996, Journal of anesthesia,
K Murakami, and T Mammoto, and T Kita, and Y Imai, and T Mashimo, and T Kirita, and M Sugimura, and Y Kishi
September 1994, Prostaglandins, leukotrienes, and essential fatty acids,
K Murakami, and T Mammoto, and T Kita, and Y Imai, and T Mashimo, and T Kirita, and M Sugimura, and Y Kishi
March 1992, Canadian journal of anaesthesia = Journal canadien d'anesthesie,
K Murakami, and T Mammoto, and T Kita, and Y Imai, and T Mashimo, and T Kirita, and M Sugimura, and Y Kishi
November 1993, Prostaglandins, leukotrienes, and essential fatty acids,
K Murakami, and T Mammoto, and T Kita, and Y Imai, and T Mashimo, and T Kirita, and M Sugimura, and Y Kishi
April 1994, Prostaglandins, leukotrienes, and essential fatty acids,
K Murakami, and T Mammoto, and T Kita, and Y Imai, and T Mashimo, and T Kirita, and M Sugimura, and Y Kishi
January 1992, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation,
Copied contents to your clipboard!